在类风湿性关节炎中双边快速破坏性皮病
Stoimen Dimitrov1, Georgi Gerganov1,2, Simona Bogdanova1,2
1Faculty of Medicine, Medical University "Prof. Dr. Paraskev Stoyanov", Varna, Bulgaria.
Reumatologia
|May 27, 2024
概括
快速破坏性病 (RDC) 是一种罕见的部疾病,可以迅速恶化,特别是在类风湿性关节炎 (RA) 患者中. 早期检测和进一步的研究对于管理这种具有挑战性的关节疾病至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 整形外科 整形外科 整形外科
- 临床医学 临床医学
背景情况:
- 快速破坏性病 (RDC) 是一种罕见的关节疾病,其特征是迅速恶化.
- RDC的确切原因尚不清楚,提出了各种病理生理机制.
- RDC带来了重大的诊断和治疗挑战,特别是与其他疾病相关联时.
研究的目的:
- 为了全面分析迅速破坏性病 (RDC).
- 调查双边RDC和类风湿性关节炎 (RA) 之间的关联.
- 突出RA患者中RDC的临床表现和诊断挑战.
主要方法:
- 进行了文献搜索,以确定有关双边RDC和RA的研究.
- 包括一个长期RA和双边RDC患者的病例介绍.
- 放射性评估被用来确认关节的破坏.
主要成果:
- 审查的重点是RDC和类风湿性关节炎 (RA) 之间的关联.
- 一个临床案例表明,在发烧后,RA患者的双边部破坏.
- 这些发现强调了RA背景下RDC的诊断和治疗复杂性.
结论:
- 迅速破坏性病,特别是与类风湿性关节炎相关时,会带来诊断和治疗方面的挑战.
- 需要警的类风湿性关节炎患者经历部参与.
- 需要进一步的研究来阐明RDC机制并改善临床管理.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammatory Bowel Disease II: Crohn's Disease
217
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
217
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158


